Low conversion rate of QuantiFERON-TB Gold screening tests in patients treated with tumor necrosis factor inhibitors: A retrospective cohort study identifying an important practice gap

J Am Acad Dermatol. 2018 Jul;79(1):169-171. doi: 10.1016/j.jaad.2018.03.025. Epub 2018 Mar 26.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Inflammatory Bowel Diseases / diagnosis
  • Inflammatory Bowel Diseases / drug therapy
  • Interferon-gamma Release Tests / methods*
  • Male
  • Mass Screening / methods*
  • Middle Aged
  • Professional Practice Gaps*
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy
  • Retrospective Studies
  • Risk Assessment
  • Treatment Outcome
  • Tuberculosis / diagnosis*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / therapeutic use
  • United States

Substances

  • Tumor Necrosis Factor-alpha